The VA Office of Inspector General (OIG) received allegations of inadequate orientation and training of pharmacy staff, a lack of pharmacist oversight of intravenous (IV) admixtures, and noncompliance with controlled substance policies. The Veterans Integrated Service Network Director initially reviewed the matter and did not substantiate the allegations but noted that some pharmacy staff’s annual IV compounding competencies had lapsed. The OIG received a second allegation that pharmacy management was noncompliant with Veterans Health Administration (VHA) controlled substance policies and initiated a healthcare inspection to evaluate the allegations and review the annual IV compounding competencies. The OIG did not substantiate inadequate pharmacist orientation and training for inpatient pharmacy, IV admixture, and the cache, and did not substantiate a lack of pharmacist oversight in technician-prepared IV admixtures. The annual required staff competencies were current. However, the OIG team noted the orientation checklists and annual competencies lacked a tracking mechanism. Pharmacy managers complied with the VHA controlled substance directive. The OIG team learned of a suspected controlled substance diversion incident that facility leaders reported to the VA police and the OIG Office of Investigations but did not report to the email group required by the VHA directive at the time. The OIG team learned of an instance where testosterone was not added to inventory records or secured in the vault. The OIG made three recommendations to the Facility Director related to developing a tracking process for orientation and annual competencies of pharmacy staff, ensuring facility leaders are trained on current VHA drug diversion reporting requirements, and conducting a review of the testosterone misplacement. Note: This matter is not related to the recent criminal case involving a former nursing assistant at the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia.
Clarksburg, WV
United States
